Brief: Biomerica - Fortel Kidney Disease Test Approved For Sale In UAE
17/04/2025 13:55
April 17 (Reuters) - Biomerica Inc BMRA.O: BIOMERICA INC - FORTEL KIDNEY DISEASE TEST APPROVED FOR SALE IN UAE Source text: ID:nGNXhxNg7 Further company coverage: BMRA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biomerica
See all newsDiagnostics firm Biomerica's Q1 revenue drops on lower clinical lab orders
Brief: Biomerica May Offer Up To $250 Million Of Common Stock, Preferred Stock, Debt Securities, & Warrants
Brief: Biomerica Lands $1.75 Million CDMO Master Services Agreement For IVD Diagnostic Development
Biomerica's Q3 revenue falls, net loss widens on lower manufacturing sales
Brief: Biomerica Q3 Net Income USD -1.31 Million